Autophagy Suppression as a Lifespan-Stage Maladaptation: When Protective Hibernation Becomes Pathological Hoarding

Autophagy suppression in aging is not a random failure but an evolutionarily conserved stress response that becomes maladaptive. The molecular brakes (mTORC1 hyperactivation, TFEB sequestration, Rubicon accumulation)[https://pmc.ncbi.nlm.nih.gov/articles/PMC11352966/] function as a 'damage-hibernation program'—minimizing turnover to protect a fragile, accumulated proteome during mid-life stress, but locking cells into a toxic stasis in late life.

Core Hypothesis: Autophagy suppression shifts from adaptive to maladaptive across the lifespan. In young organisms, transient suppression during acute stress (infection, injury) prevents excessive self-digestion. In aging, this suppression becomes chronic and rigid, not because the machinery is broken, but because the regulatory threshold for reactivation has been epigenetically raised. The system interprets accumulated damage as an ongoing crisis requiring perpetual hibernation.

Mechanistic Prediction: Senescent cells represent the endpoint of this maladaptation. Their persistent, starvation-insensitive mTORC1 signaling[https://doi.org/10.1083/jcb.201610113] isn't just a metabolic quirk—it's a locked state where the cell has internalized its own damage signals as the new baseline for survival. The rewired nutrient sensing maintains amino acid pools[https://doi.org/10.1083/jcb.201610113] not for proliferation, but to avoid the 'emptiness' of a full autophagic reset that might destabilize a damaged but still-metabolically-active state.

Testable Predictions:

1. Lifespan Trajectory: Autophagy flux markers (LC3-II/I ratio, p62 levels) will show a non-monotonic pattern: high in youth, suppressed in middle age (stress period), and variably low in old age (senescent burden). Suppression intensity in mid-life should correlate with later senescent cell burden.
2. Tissue-Specific Triggers: Different tissues accumulate different molecular brakes[https://pmc.ncbi.nlm.nih.gov/articles/PMC11352966/] because their primary stress triggers differ. Cardiac ATG9 reduction[https://pmc.ncbi.nlm.nih.gov/articles/PMC11352966/] may protect against Ca²⁺-mediated autophagy during frequent ischemia-reperfusion; neuronal WIPI2 impairment[https://pmc.ncbi.nlm.nih.gov/articles/PMC11352966/] may prevent excessive synaptic pruning.
3. Fasting Response Gradient: The efficacy of caloric restriction in reactivating autophagy[https://www.fightaging.org/archives/2024/04/calorie-restriction-and-fasting-benefit-the-aging-heart/][https://www.aging-us.com/article/100996/text] should inversely correlate with cellular senescence markers (p16, SA-β-gal). Cells with the highest senescence scores will show the weakest AMPK response and minimal TFEB nuclear translocation despite fasting.
4. Pharmacological Challenge: Direct AMPK activators (like metformin) or mTORC1 inhibitors (like rapamycin) should temporarily break suppression, but repeated dosing will show diminishing returns as cells adapt—supporting the idea of a raised reactivation threshold.

Falsification Criteria: If autophagy flux in non-senescent aged cells cannot be restored to youthful levels by combined suppression-lifting interventions (senolytics + fasting + mTOR inhibition), the hypothesis fails. Similarly, if mid-life stress events do not predict late-life autophagy suppression, the adaptive-to-maladaptive transition model is incorrect.

This framework suggests that therapeutic autophagy induction must overcome not just current suppression, but the epigenetic memory of past stress that reset the activation threshold. Simply removing brakes may be insufficient; we may need to reset the system's definition of 'safe' turnover levels.